PAYMENT DETAILS

  • Order Details
    1
  • Confirm
    2

Order Details

Are you one of the authors of this manuscript?
No. of Copies
 
(minmum 25 copies)

Billing and Shipping Addresses

Billing Address

Payer Name
Email
Phone
Address
City
Country
Tax/Customs info
(e.g. 'CPF/CNPJ', 'RUT','EORI', or 'NPWP')

Shipping Address

Attention of
Email
Phone
Address
(P.O. Box is not allowed)
City
Country

Note: if you do not confirm your information in step 2, your information will not be saved.

Article Details

Journal Title
Advances in Hematology
Volume
2022
Article Title
Ibrutinib plus Obinutuzumab as Frontline Therapy for Chronic Lymphocytic Leukemia Is Associated with a Lower Rate of Infusion-Related Reactions and with Sustained Remissions after Ibrutinib Discontinuation: A Single-Arm, Open-Label, Phase 1b/2 Clinical Trial NCT0231576
List of Authors
  • Paula A. Lengerke-Diaz(ORCID ID: https://orcid.org/0000-0002-1285-8499)
  • Juliana Velez Lujan
  • Michael Y. Choi(ORCID ID: https://orcid.org/0000-0002-9107-2186)
  • Eider F. Moreno-Cortes(ORCID ID: https://orcid.org/0000-0001-7629-6264)
  • Jose V. Forero(ORCID ID: https://orcid.org/0000-0001-9872-5760)
  • Juan Esteban Garcia-Robledo(ORCID ID: https://orcid.org/0000-0003-2912-152X)
  • Chaja Jacobs(ORCID ID: https://orcid.org/0000-0002-7294-4364)
  • Colin McCarthy
  • Alaina Heinen
  • Carlos I. Amaya-Chanaga
  • Thomas J. Kipps(ORCID ID: https://orcid.org/0000-0002-0064-4549)
Article ID
4450824
Article Type
Research Article
No. of Pages
8 Pages
Corresponding Author
Januario E. Castro
Additional Authors

Invoice Details

Invoice Issue Date
26 April 2024
Type of Reprints
Colored, Covered
Invoice Ref. No.
Terms
Payable upon Receipt

Charges

No. of Copies
Reprints Charges
0.00
Total
$